Furthermore, GLP1-RA treatment was associated with a reduced incidence of heart failure compared to SGLT-2i (sHR 0.66, 95% CI 0.55–0.80) and hypertension relative to sulfonylurea (sHR 0.72, 95% CI 0.65–0.80). Here, GLP1R is linked to heart failure.